Report Detail

Table of Contents

    1 Recombinant Peptides Market Overview

    • 1.1 Recombinant Peptides Product Overview
    • 1.2 Recombinant Peptides Market Segment by Type
      • 1.2.1 Glucagon
      • 1.2.2 Calcitonin
      • 1.2.3 Other
    • 1.3 Global Recombinant Peptides Market Size by Type
      • 1.3.1 Global Recombinant Peptides Sales and Growth by Type
      • 1.3.2 Global Recombinant Peptides Sales and Market Share by Type (2013-2018)
      • 1.3.3 Global Recombinant Peptides Revenue and Market Share by Type (2013-2018)
      • 1.3.4 Global Recombinant Peptides Price by Type (2013-2018)

    2 Global Recombinant Peptides Market Competition by Company

    • 2.1 Global Recombinant Peptides Sales and Market Share by Company (2013-2018)
    • 2.2 Global Recombinant Peptides Revenue and Share by Company (2013-2018)
    • 2.3 Global Recombinant Peptides Price by Company (2013-2018)
    • 2.4 Global Top Players Recombinant Peptides Manufacturing Base Distribution, Sales Area, Product Types
    • 2.5 Recombinant Peptides Market Competitive Situation and Trends
      • 2.5.1 Recombinant Peptides Market Concentration Rate
      • 2.5.2 Global Recombinant Peptides Market Share of Top 5 and Top 10 Players
      • 2.5.3 Mergers & Acquisitions, Expansion

    3 Recombinant Peptides Company Profiles and Sales Data

    • 3.1 Sandoz Pharma
      • 3.1.1 Company Basic Information, Manufacturing Base and Competitors
      • 3.1.2 Recombinant Peptides Product Category, Application and Specification
      • 3.1.3 Sandoz Pharma Recombinant Peptides Sales, Revenue, Price and Gross Margin(2013-2018)
      • 3.1.4 Main Business Overview
    • 3.2 Stada Arzneimittel
      • 3.2.1 Company Basic Information, Manufacturing Base and Competitors
      • 3.2.2 Recombinant Peptides Product Category, Application and Specification
      • 3.2.3 Stada Arzneimittel Recombinant Peptides Sales, Revenue, Price and Gross Margin(2013-2018)
      • 3.2.4 Main Business Overview
    • 3.3 Amgen
      • 3.3.1 Company Basic Information, Manufacturing Base and Competitors
      • 3.3.2 Recombinant Peptides Product Category, Application and Specification
      • 3.3.3 Amgen Recombinant Peptides Sales, Revenue, Price and Gross Margin(2013-2018)
      • 3.3.4 Main Business Overview
    • 3.4 Hospira
      • 3.4.1 Company Basic Information, Manufacturing Base and Competitors
      • 3.4.2 Recombinant Peptides Product Category, Application and Specification
      • 3.4.3 Hospira Recombinant Peptides Sales, Revenue, Price and Gross Margin(2013-2018)
      • 3.4.4 Main Business Overview
    • 3.5 Actavis
      • 3.5.1 Company Basic Information, Manufacturing Base and Competitors
      • 3.5.2 Recombinant Peptides Product Category, Application and Specification
      • 3.5.3 Actavis Recombinant Peptides Sales, Revenue, Price and Gross Margin(2013-2018)
      • 3.5.4 Main Business Overview
    • 3.6 Cipla Ltd.
      • 3.6.1 Company Basic Information, Manufacturing Base and Competitors
      • 3.6.2 Recombinant Peptides Product Category, Application and Specification
      • 3.6.3 Cipla Ltd. Recombinant Peptides Sales, Revenue, Price and Gross Margin(2013-2018)
      • 3.6.4 Main Business Overview
    • 3.7 Wockhardt Ltd.
      • 3.7.1 Company Basic Information, Manufacturing Base and Competitors
      • 3.7.2 Recombinant Peptides Product Category, Application and Specification
      • 3.7.3 Wockhardt Ltd. Recombinant Peptides Sales, Revenue, Price and Gross Margin(2013-2018)
      • 3.7.4 Main Business Overview
    • 3.8 Biocon Ltd.
      • 3.8.1 Company Basic Information, Manufacturing Base and Competitors
      • 3.8.2 Recombinant Peptides Product Category, Application and Specification
      • 3.8.3 Biocon Ltd. Recombinant Peptides Sales, Revenue, Price and Gross Margin(2013-2018)
      • 3.8.4 Main Business Overview

    4 Recombinant Peptides Market Status and Outlook by Regions

    • 4.1 Global Market Status and Outlook by Regions
      • 4.1.1 Global Recombinant Peptides Market Size and CAGR by Regions
      • 4.1.2 North America
      • 4.1.3 Asia-Pacific
      • 4.1.4 Europe
      • 4.1.5 South America
      • 4.1.6 Middle East and Africa
    • 4.2 Global Recombinant Peptides Sales and Revenue by Regions
      • 4.2.1 Global Recombinant Peptides Sales and Market Share by Regions (2013-2018)
      • 4.2.2 Global Recombinant Peptides Revenue and Market Share by Regions (2013-2018)
      • 4.2.3 Global Recombinant Peptides Sales, Revenue, Price and Gross Margin (2013-2018)
    • 4.3 North America Recombinant Peptides Sales, Revenue, Price and Gross Margin
      • 4.3.1 United States
      • 4.3.2 Canada
      • 4.3.3 Mexico
    • 4.4 Europe Recombinant Peptides Sales, Revenue, Price and Gross Margin
      • 4.4.1 Germany
      • 4.4.2 UK
      • 4.4.3 France
      • 4.4.4 Italy
      • 4.4.5 Russia
      • 4.4.6 Turkey
    • 4.5 Asia-Pacific Recombinant Peptides Sales, Revenue, Price and Gross Margin
      • 4.5.1 China
      • 4.5.2 Japan
      • 4.5.3 Korea
      • 4.5.4 Southeast Asia
        • 4.5.4.1 Indonesia
        • 4.5.4.2 Thailand
        • 4.5.4.3 Malaysia
        • 4.5.4.4 Philippines
        • 4.5.4.5 Vietnam
      • 4.5.5 India
      • 4.5.6 Australia
    • 4.6 South America Recombinant Peptides Sales, Revenue, Price and Gross Margin
      • 4.6.1 Brazil
    • 4.7 Middle East and Africa Recombinant Peptides Sales, Revenue, Price and Gross Margin
      • 4.7.1 Egypt
      • 4.7.2 GCC Countries

    5 Recombinant Peptides Application/End Users

    • 5.1 Recombinant Peptides Segment by Application
      • 5.1.1 Oncology
      • 5.1.2 Blood Disorders
      • 5.1.3 Infectious Diseases
      • 5.1.4 Autoimmune Diseases
      • 5.1.5 Other
    • 5.2 Global Recombinant Peptides Product Segment by Application
      • 5.2.1 Global Recombinant Peptides Sales by Application
      • 5.2.2 Global Recombinant Peptides Sales and Market Share by Application (2013-2018)

    6 Global Recombinant Peptides Market Forecast

    • 6.1 Global Recombinant Peptides Sales, Revenue Forecast (2018-2025)
      • 6.1.1 Global Recombinant Peptides Sales and Growth Rate Forecast (2018-2025)
      • 6.1.1 Global Recombinant Peptides Revenue and Growth Rate Forecast (2018-2025)
    • 6.2 Global Recombinant Peptides Forecast by Regions
      • 6.2.1 North America Recombinant Peptides Sales and Revenue Forecast (2018-2025)
      • 6.2.2 Europe Recombinant Peptides Sales and Revenue Forecast (2018-2025)
      • 6.2.3 Asia-Pacific Recombinant Peptides Sales and Revenue Forecast (2018-2025)
        • 6.2.3.1 China
        • 6.2.3.2 Japan
        • 6.2.3.3 Korea
        • 6.2.3.4 Southeast Asia
        • 6.2.3.5 India
        • 6.2.3.6 Australia
      • 6.2.4 South America Recombinant Peptides Sales and Revenue Forecast (2018-2025)
      • 6.2.5 Middle East and Africa Recombinant Peptides Sales and Revenue Forecast (2018-2025)
        • 6.2.5.1 Egypt
        • 6.2.5.2 GCC Countries
    • 6.3 Recombinant Peptides Forecast by Type
      • 6.3.1 Global Recombinant Peptides Sales and Revenue Forecast by Type (2018-2025)
      • 6.3.2 Glucagon Gowth Forecast
      • 6.3.3 Calcitonin Gowth Forecast
    • 6.4 Recombinant Peptides Forecast by Application
      • 6.4.1 Global Recombinant Peptides Sales Forecast by Application (2018-2025)
      • 6.4.2 Global Recombinant Peptides Forecast in Oncology
      • 6.4.3 Global Recombinant Peptides Forecast in Blood Disorders

    7 Recombinant Peptides Upstream Raw Materials

    • 7.1 Recombinant Peptides Key Raw Materials
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Raw Materials Price
      • 7.1.3 Raw Materials Key Suppliers
    • 7.2 Manufacturing Cost Structure
      • 7.2.1 Raw Materials
      • 7.2.2 Labor Cost
      • 7.2.3 Manufacturing Expenses
    • 7.3 Recombinant Peptides Industrial Chain Analysis

    8 Marketing Strategy Analysis, Distributors

    • 8.1 Marketing Channel
      • 8.1.1 Direct Marketing
      • 8.1.2 Indirect Marketing
      • 8.1.3 Marketing Channel Development Trend
    • 8.2 Distributors
    • 8.3 Downstream Customers

    9 Research Findings and Conclusion

      Appendix

        Methodology/Research Approach

          Research Programs/Design

            Market Size Estimation

              Market Breakdown and Data Triangulation

                Data Source

                  Secondary Sources

                    Primary Sources

                      Disclaimer

                      Summary

                      This report studies the Recombinant Peptides market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

                      The global Recombinant Peptides market was xx million US$ in 2017 and is expected to xx million US$ by the end of 2025, growing at a CAGR of xx% between 2018 and 2025.

                      Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Recombinant Peptides in these regions, from 2013 to 2025, covering
                      North America (United States, Canada and Mexico)
                      Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
                      Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
                      South America (Brazil etc.)
                      Middle East and Africa (Egypt and GCC Countries)

                      The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
                      Sandoz Pharma
                      Stada Arzneimittel
                      Amgen
                      Hospira
                      Actavis
                      Cipla Ltd.
                      Wockhardt Ltd.
                      Biocon Ltd.
                      By the product type, the market is primarily split into
                      Glucagon
                      Calcitonin
                      Other
                      By the end users/application, this report covers the following segments
                      Oncology
                      Blood Disorders
                      Infectious Diseases
                      Autoimmune Diseases
                      Other

                      We can also provide the customized separate regional or country-level reports, for the following regions:
                      North America
                      United States
                      Canada
                      Mexico
                      Asia-Pacific
                      China
                      India
                      Japan
                      South Korea
                      Australia
                      Indonesia
                      Singapore
                      Malaysia
                      Philippines
                      Thailand
                      Vietnam
                      Rest of Asia-Pacific
                      Europe
                      Germany
                      France
                      UK
                      Italy
                      Spain
                      Russia
                      Rest of Europe
                      Central & South America
                      Brazil
                      Rest of Central & South America
                      Middle East & Africa
                      GCC Countries
                      Turkey
                      Egypt
                      South Africa
                      Rest of Middle East & Africa

                      The study objectives of this report are:
                      To study and analyze the global Recombinant Peptides market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
                      To understand the structure of Recombinant Peptides market by identifying its various subsegments.
                      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
                      Focuses on the key global Recombinant Peptides manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
                      To analyze the Recombinant Peptides with respect to individual growth trends, future prospects, and their contribution to the total market.
                      To project the value and volume of Recombinant Peptides submarkets, with respect to key regions (along with their respective key countries).
                      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
                      To strategically profile the key players and comprehensively analyze their growth strategies.

                      In this study, the years considered to estimate the market size of Recombinant Peptides are as follows:
                      History Year: 2013-2017
                      Base Year: 2017
                      Estimated Year: 2018
                      Forecast Year 2018 to 2025

                      This report includes the estimation of market size for value (million USD) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Recombinant Peptides market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

                      For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

                      Key Stakeholders
                      Raw material suppliers
                      Distributors/traders/wholesalers/suppliers
                      Regulatory bodies, including government agencies and NGO
                      Commercial research & development (R&D) institutions
                      Importers and exporters
                      Government organizations, research organizations, and consulting firms
                      Trade associations and industry bodies
                      End-use industries

                      Available Customizations
                      With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
                      Further breakdown of Recombinant Peptides market on basis of the key contributing countries.
                      Detailed analysis and profiling of additional market players.


                      Summary:
                      Get latest Market Research Reports on Recombinant Peptides . Industry analysis & Market Report on Recombinant Peptides is a syndicated market report, published as Global Recombinant Peptides Market Report, History and Forecast 2013-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of Recombinant Peptides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                      Last updated on

                      REPORT YOU MIGHT BE INTERESTED

                      Purchase this Report

                      $3,600.00
                      $7,200.00
                      2,584.80
                      5,169.60
                      3,027.60
                      6,055.20
                      394,740.00
                      789,480.00
                      267,624.00
                      535,248.00
                      Credit card Logo

                      Related Reports


                      Reason to Buy

                      Request for Sample of this report